It is the first time the Senate has been called upon to confirm a C.D.C. director. Dr. Dave Weldon has close ties to Robert F ...

Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive safe ...

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

Since 2022, the USDA reports more than 150 million chickens and turkeys have been lost to Highly Pathogenic Avian Influenza (HPAI) in the United States. The loss of laying hens has contributed to an ...

Coherus BioSciences, Inc. ( NASDAQ: CHRS) Q4 2024 Earnings Conference Call March 10, 2025 5:00 PM ET Jodi Sievers - Head of IR Denny Lanfear - CEO Paul Reider - CCO Sameer Goregaoker - SVP, ...

A car accident. A football tackle. An unfortunate fall. These things—and more—can cause head injuries. Head injuries can happen to anyone, at any age, and they can damage the brain.

A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

Mission Barns has earned FDA regulatory approval to sell cultivated pork fat in the US, with its meat products set to launch ...

Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.

Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.

House Bill 1879 passed unanimously March 4 on a 95-0 vote, according to the chamber's website. State senators will now ...

Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of ...